Phytoconstituents of Gmelina Arborea as Potential Breast Cancer Inhibitors: LC‐MS/MS, Docking, MD Simulations, and In Vitro Evaluation

Documenti analoghi

• Separation and characterization of hydrolytic degradation product of deucravacitinib by validated high‐performance liquid chromatography method and liquid chromatography‐mass spectrometry
  di: Vijaya Madhyanapu Golla, et al.
  Pubblicazione: (2024)
• Analytical Quality by Design Enabled Green RP‐HPLC Method Development and Validation for the Simultaneous Quantitation of the Cleaning Residues of Osimertinib, Binimetinib, and Erdafitinib: An Approach to Prevent the Cross‐Contamination in Shared Facilities of Pharmaceutical Manufacturing
  di: Jainendra Kumar Jain, et al.
  Pubblicazione: (2025)
• An Eco‐Friendly and Quality‐by‐Design Optimized Synchronous Spectrofluorescence Method for the Simultaneous Determination of Cleaning Residues of Anticancer Drugs Darolutamide and Enzalutamide From Manufacturing Surfaces
  di: Jainendra Kumar Jain, et al.
  Pubblicazione: (2025)
• Integrative Study on Triclabendazole Stability: Forced Degradation and In Silico Toxicity Prediction of Degradation Products
  di: Kavita Pimpre, et al.
  Pubblicazione: (2025)
• Phenolic Profiling of Laurus nobilis by LC–ESI–MS/MS: In Vitro Bioactivities and In Silico Enzyme Docking
  di: Funda Erşen Bak, et al.
  Pubblicazione: (2026)